Robert J Griffin

3PUBLICATIONS
36CO-AUTHORS
Molecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 24, 2024
A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants.

Michael J Hanley, Steven Zhang, Robert Griffin

|Jul 26, 2023
Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor.

Neeraj Gupta, Michael J Hanley, Robert J Griffin

|Sep 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome.

Stanley C Xie, Riley D Metcalfe, Hirotake Mizutani

Pageof 1

Frequent Collaborators

2 joint publications

Michael J Hanley

2 joint publications

Karthik Venkatakrishnan

2 joint publications

Neeraj Gupta

1 joint publications

Sean Xiaochun Zhu